ARCHIVES

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987